Global Oncolytic Virus Manufacturing Services Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Oncolytic virus manufacturing services refer to specialized biomanufacturing processes that involve the production of oncolytic viruses, which are viruses engineered or naturally occurring that selectively infect and kill cancer cells. These services encompass a range of activities, from virus design and development to large-scale production and quality control, ensuring that the oncolytic viruses are safe, effective, and meet regulatory standards for clinical and commercial use.
The global Oncolytic Virus Manufacturing Services market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Oncolytic Virus Manufacturing Services Industry Forecast” looks at past sales and reviews total world Oncolytic Virus Manufacturing Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Oncolytic Virus Manufacturing Services sales for 2023 through 2029. With Oncolytic Virus Manufacturing Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncolytic Virus Manufacturing Services industry.
This Insight Report provides a comprehensive analysis of the global Oncolytic Virus Manufacturing Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oncolytic Virus Manufacturing Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncolytic Virus Manufacturing Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncolytic Virus Manufacturing Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncolytic Virus Manufacturing Services.
United States market for Oncolytic Virus Manufacturing Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Oncolytic Virus Manufacturing Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Oncolytic Virus Manufacturing Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Oncolytic Virus Manufacturing Services players cover Recipharm (Vibalogics), IDT Biologika, FUJIFILM Diosynth Biotechnologies, Exothera, Lonza, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncolytic Virus Manufacturing Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Oncolytic virus manufacturing services refer to specialized biomanufacturing processes that involve the production of oncolytic viruses, which are viruses engineered or naturally occurring that selectively infect and kill cancer cells. These services encompass a range of activities, from virus design and development to large-scale production and quality control, ensuring that the oncolytic viruses are safe, effective, and meet regulatory standards for clinical and commercial use.
The global Oncolytic Virus Manufacturing Services market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Oncolytic Virus Manufacturing Services Industry Forecast” looks at past sales and reviews total world Oncolytic Virus Manufacturing Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Oncolytic Virus Manufacturing Services sales for 2023 through 2029. With Oncolytic Virus Manufacturing Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncolytic Virus Manufacturing Services industry.
This Insight Report provides a comprehensive analysis of the global Oncolytic Virus Manufacturing Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oncolytic Virus Manufacturing Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncolytic Virus Manufacturing Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncolytic Virus Manufacturing Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncolytic Virus Manufacturing Services.
United States market for Oncolytic Virus Manufacturing Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Oncolytic Virus Manufacturing Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Oncolytic Virus Manufacturing Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Oncolytic Virus Manufacturing Services players cover Recipharm (Vibalogics), IDT Biologika, FUJIFILM Diosynth Biotechnologies, Exothera, Lonza, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncolytic Virus Manufacturing Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Oncolytic Herpes Simplex Virus
- Oncolytic Adenovirus
- Oncolytic Vaccinia Virus
- Others
- R&D
- Biopharmaceutical Manufacturers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Oncolytic Herpes Simplex Virus
- Oncolytic Adenovirus
- Oncolytic Vaccinia Virus
- Others
- R&D
- Biopharmaceutical Manufacturers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Recipharm (Vibalogics)
- IDT Biologika
- FUJIFILM Diosynth Biotechnologies
- Exothera
- Lonza
- Creative Biolabs
- Takara Bio
- Libentech
- ABL
- Nabios
- Halix
- Obio Technology
- Porton Advanced
- WuXi ATU
- Genevoyager
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncolytic Virus Manufacturing Services Market Size 2019-2030
2.1.2 Oncolytic Virus Manufacturing Services Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Oncolytic Virus Manufacturing Services by Country/Region, 2019, 2023 & 2030
2.2 Oncolytic Virus Manufacturing Services Segment by Type
2.2.1 Oncolytic Herpes Simplex Virus
2.2.2 Oncolytic Adenovirus
2.2.3 Oncolytic Vaccinia Virus
2.2.4 Others
2.3 Oncolytic Virus Manufacturing Services Market Size by Type
2.3.1 Oncolytic Virus Manufacturing Services Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Oncolytic Virus Manufacturing Services Market Size Market Share by Type (2019-2024)
2.4 Oncolytic Virus Manufacturing Services Segment by Application
2.4.1 R&D
2.4.2 Biopharmaceutical Manufacturers
2.4.3 Others
2.5 Oncolytic Virus Manufacturing Services Market Size by Application
2.5.1 Oncolytic Virus Manufacturing Services Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Oncolytic Virus Manufacturing Services Market Size Market Share by Application (2019-2024)
3 ONCOLYTIC VIRUS MANUFACTURING SERVICES MARKET SIZE BY PLAYER
3.1 Oncolytic Virus Manufacturing Services Market Size Market Share by Player
3.1.1 Global Oncolytic Virus Manufacturing Services Revenue by Player (2019-2024)
3.1.2 Global Oncolytic Virus Manufacturing Services Revenue Market Share by Player (2019-2024)
3.2 Global Oncolytic Virus Manufacturing Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLYTIC VIRUS MANUFACTURING SERVICES BY REGION
4.1 Oncolytic Virus Manufacturing Services Market Size by Region (2019-2024)
4.2 Global Oncolytic Virus Manufacturing Services Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oncolytic Virus Manufacturing Services Market Size Growth (2019-2024)
4.4 APAC Oncolytic Virus Manufacturing Services Market Size Growth (2019-2024)
4.5 Europe Oncolytic Virus Manufacturing Services Market Size Growth (2019-2024)
4.6 Middle East & Africa Oncolytic Virus Manufacturing Services Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Oncolytic Virus Manufacturing Services Market Size by Country (2019-2024)
5.2 Americas Oncolytic Virus Manufacturing Services Market Size by Type (2019-2024)
5.3 Americas Oncolytic Virus Manufacturing Services Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncolytic Virus Manufacturing Services Market Size by Region (2019-2024)
6.2 APAC Oncolytic Virus Manufacturing Services Market Size by Type (2019-2024)
6.3 APAC Oncolytic Virus Manufacturing Services Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncolytic Virus Manufacturing Services Market Size by Country (2019-2024)
7.2 Europe Oncolytic Virus Manufacturing Services Market Size by Type (2019-2024)
7.3 Europe Oncolytic Virus Manufacturing Services Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncolytic Virus Manufacturing Services by Region (2019-2024)
8.2 Middle East & Africa Oncolytic Virus Manufacturing Services Market Size by Type (2019-2024)
8.3 Middle East & Africa Oncolytic Virus Manufacturing Services Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLYTIC VIRUS MANUFACTURING SERVICES MARKET FORECAST
10.1 Global Oncolytic Virus Manufacturing Services Forecast by Region (2025-2030)
10.1.1 Global Oncolytic Virus Manufacturing Services Forecast by Region (2025-2030)
10.1.2 Americas Oncolytic Virus Manufacturing Services Forecast
10.1.3 APAC Oncolytic Virus Manufacturing Services Forecast
10.1.4 Europe Oncolytic Virus Manufacturing Services Forecast
10.1.5 Middle East & Africa Oncolytic Virus Manufacturing Services Forecast
10.2 Americas Oncolytic Virus Manufacturing Services Forecast by Country (2025-2030)
10.2.1 United States Market Oncolytic Virus Manufacturing Services Forecast
10.2.2 Canada Market Oncolytic Virus Manufacturing Services Forecast
10.2.3 Mexico Market Oncolytic Virus Manufacturing Services Forecast
10.2.4 Brazil Market Oncolytic Virus Manufacturing Services Forecast
10.3 APAC Oncolytic Virus Manufacturing Services Forecast by Region (2025-2030)
10.3.1 China Oncolytic Virus Manufacturing Services Market Forecast
10.3.2 Japan Market Oncolytic Virus Manufacturing Services Forecast
10.3.3 Korea Market Oncolytic Virus Manufacturing Services Forecast
10.3.4 Southeast Asia Market Oncolytic Virus Manufacturing Services Forecast
10.3.5 India Market Oncolytic Virus Manufacturing Services Forecast
10.3.6 Australia Market Oncolytic Virus Manufacturing Services Forecast
10.4 Europe Oncolytic Virus Manufacturing Services Forecast by Country (2025-2030)
10.4.1 Germany Market Oncolytic Virus Manufacturing Services Forecast
10.4.2 France Market Oncolytic Virus Manufacturing Services Forecast
10.4.3 UK Market Oncolytic Virus Manufacturing Services Forecast
10.4.4 Italy Market Oncolytic Virus Manufacturing Services Forecast
10.4.5 Russia Market Oncolytic Virus Manufacturing Services Forecast
10.5 Middle East & Africa Oncolytic Virus Manufacturing Services Forecast by Region (2025-2030)
10.5.1 Egypt Market Oncolytic Virus Manufacturing Services Forecast
10.5.2 South Africa Market Oncolytic Virus Manufacturing Services Forecast
10.5.3 Israel Market Oncolytic Virus Manufacturing Services Forecast
10.5.4 Turkey Market Oncolytic Virus Manufacturing Services Forecast
10.6 Global Oncolytic Virus Manufacturing Services Forecast by Type (2025-2030)
10.7 Global Oncolytic Virus Manufacturing Services Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Oncolytic Virus Manufacturing Services Forecast
11 KEY PLAYERS ANALYSIS
11.1 Recipharm (Vibalogics)
11.1.1 Recipharm (Vibalogics) Company Information
11.1.2 Recipharm (Vibalogics) Oncolytic Virus Manufacturing Services Product Offered
11.1.3 Recipharm (Vibalogics) Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Recipharm (Vibalogics) Main Business Overview
11.1.5 Recipharm (Vibalogics) Latest Developments
11.2 IDT Biologika
11.2.1 IDT Biologika Company Information
11.2.2 IDT Biologika Oncolytic Virus Manufacturing Services Product Offered
11.2.3 IDT Biologika Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 IDT Biologika Main Business Overview
11.2.5 IDT Biologika Latest Developments
11.3 FUJIFILM Diosynth Biotechnologies
11.3.1 FUJIFILM Diosynth Biotechnologies Company Information
11.3.2 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing Services Product Offered
11.3.3 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.3.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.4 Exothera
11.4.1 Exothera Company Information
11.4.2 Exothera Oncolytic Virus Manufacturing Services Product Offered
11.4.3 Exothera Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Exothera Main Business Overview
11.4.5 Exothera Latest Developments
11.5 Lonza
11.5.1 Lonza Company Information
11.5.2 Lonza Oncolytic Virus Manufacturing Services Product Offered
11.5.3 Lonza Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Lonza Main Business Overview
11.5.5 Lonza Latest Developments
11.6 Creative Biolabs
11.6.1 Creative Biolabs Company Information
11.6.2 Creative Biolabs Oncolytic Virus Manufacturing Services Product Offered
11.6.3 Creative Biolabs Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Creative Biolabs Main Business Overview
11.6.5 Creative Biolabs Latest Developments
11.7 Takara Bio
11.7.1 Takara Bio Company Information
11.7.2 Takara Bio Oncolytic Virus Manufacturing Services Product Offered
11.7.3 Takara Bio Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Takara Bio Main Business Overview
11.7.5 Takara Bio Latest Developments
11.8 Libentech
11.8.1 Libentech Company Information
11.8.2 Libentech Oncolytic Virus Manufacturing Services Product Offered
11.8.3 Libentech Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Libentech Main Business Overview
11.8.5 Libentech Latest Developments
11.9 ABL
11.9.1 ABL Company Information
11.9.2 ABL Oncolytic Virus Manufacturing Services Product Offered
11.9.3 ABL Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 ABL Main Business Overview
11.9.5 ABL Latest Developments
11.10 Nabios
11.10.1 Nabios Company Information
11.10.2 Nabios Oncolytic Virus Manufacturing Services Product Offered
11.10.3 Nabios Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Nabios Main Business Overview
11.10.5 Nabios Latest Developments
11.11 Halix
11.11.1 Halix Company Information
11.11.2 Halix Oncolytic Virus Manufacturing Services Product Offered
11.11.3 Halix Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Halix Main Business Overview
11.11.5 Halix Latest Developments
11.12 Obio Technology
11.12.1 Obio Technology Company Information
11.12.2 Obio Technology Oncolytic Virus Manufacturing Services Product Offered
11.12.3 Obio Technology Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Obio Technology Main Business Overview
11.12.5 Obio Technology Latest Developments
11.13 Porton Advanced
11.13.1 Porton Advanced Company Information
11.13.2 Porton Advanced Oncolytic Virus Manufacturing Services Product Offered
11.13.3 Porton Advanced Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Porton Advanced Main Business Overview
11.13.5 Porton Advanced Latest Developments
11.14 WuXi ATU
11.14.1 WuXi ATU Company Information
11.14.2 WuXi ATU Oncolytic Virus Manufacturing Services Product Offered
11.14.3 WuXi ATU Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 WuXi ATU Main Business Overview
11.14.5 WuXi ATU Latest Developments
11.15 Genevoyager
11.15.1 Genevoyager Company Information
11.15.2 Genevoyager Oncolytic Virus Manufacturing Services Product Offered
11.15.3 Genevoyager Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Genevoyager Main Business Overview
11.15.5 Genevoyager Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncolytic Virus Manufacturing Services Market Size 2019-2030
2.1.2 Oncolytic Virus Manufacturing Services Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Oncolytic Virus Manufacturing Services by Country/Region, 2019, 2023 & 2030
2.2 Oncolytic Virus Manufacturing Services Segment by Type
2.2.1 Oncolytic Herpes Simplex Virus
2.2.2 Oncolytic Adenovirus
2.2.3 Oncolytic Vaccinia Virus
2.2.4 Others
2.3 Oncolytic Virus Manufacturing Services Market Size by Type
2.3.1 Oncolytic Virus Manufacturing Services Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Oncolytic Virus Manufacturing Services Market Size Market Share by Type (2019-2024)
2.4 Oncolytic Virus Manufacturing Services Segment by Application
2.4.1 R&D
2.4.2 Biopharmaceutical Manufacturers
2.4.3 Others
2.5 Oncolytic Virus Manufacturing Services Market Size by Application
2.5.1 Oncolytic Virus Manufacturing Services Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Oncolytic Virus Manufacturing Services Market Size Market Share by Application (2019-2024)
3 ONCOLYTIC VIRUS MANUFACTURING SERVICES MARKET SIZE BY PLAYER
3.1 Oncolytic Virus Manufacturing Services Market Size Market Share by Player
3.1.1 Global Oncolytic Virus Manufacturing Services Revenue by Player (2019-2024)
3.1.2 Global Oncolytic Virus Manufacturing Services Revenue Market Share by Player (2019-2024)
3.2 Global Oncolytic Virus Manufacturing Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLYTIC VIRUS MANUFACTURING SERVICES BY REGION
4.1 Oncolytic Virus Manufacturing Services Market Size by Region (2019-2024)
4.2 Global Oncolytic Virus Manufacturing Services Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oncolytic Virus Manufacturing Services Market Size Growth (2019-2024)
4.4 APAC Oncolytic Virus Manufacturing Services Market Size Growth (2019-2024)
4.5 Europe Oncolytic Virus Manufacturing Services Market Size Growth (2019-2024)
4.6 Middle East & Africa Oncolytic Virus Manufacturing Services Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Oncolytic Virus Manufacturing Services Market Size by Country (2019-2024)
5.2 Americas Oncolytic Virus Manufacturing Services Market Size by Type (2019-2024)
5.3 Americas Oncolytic Virus Manufacturing Services Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncolytic Virus Manufacturing Services Market Size by Region (2019-2024)
6.2 APAC Oncolytic Virus Manufacturing Services Market Size by Type (2019-2024)
6.3 APAC Oncolytic Virus Manufacturing Services Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncolytic Virus Manufacturing Services Market Size by Country (2019-2024)
7.2 Europe Oncolytic Virus Manufacturing Services Market Size by Type (2019-2024)
7.3 Europe Oncolytic Virus Manufacturing Services Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncolytic Virus Manufacturing Services by Region (2019-2024)
8.2 Middle East & Africa Oncolytic Virus Manufacturing Services Market Size by Type (2019-2024)
8.3 Middle East & Africa Oncolytic Virus Manufacturing Services Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLYTIC VIRUS MANUFACTURING SERVICES MARKET FORECAST
10.1 Global Oncolytic Virus Manufacturing Services Forecast by Region (2025-2030)
10.1.1 Global Oncolytic Virus Manufacturing Services Forecast by Region (2025-2030)
10.1.2 Americas Oncolytic Virus Manufacturing Services Forecast
10.1.3 APAC Oncolytic Virus Manufacturing Services Forecast
10.1.4 Europe Oncolytic Virus Manufacturing Services Forecast
10.1.5 Middle East & Africa Oncolytic Virus Manufacturing Services Forecast
10.2 Americas Oncolytic Virus Manufacturing Services Forecast by Country (2025-2030)
10.2.1 United States Market Oncolytic Virus Manufacturing Services Forecast
10.2.2 Canada Market Oncolytic Virus Manufacturing Services Forecast
10.2.3 Mexico Market Oncolytic Virus Manufacturing Services Forecast
10.2.4 Brazil Market Oncolytic Virus Manufacturing Services Forecast
10.3 APAC Oncolytic Virus Manufacturing Services Forecast by Region (2025-2030)
10.3.1 China Oncolytic Virus Manufacturing Services Market Forecast
10.3.2 Japan Market Oncolytic Virus Manufacturing Services Forecast
10.3.3 Korea Market Oncolytic Virus Manufacturing Services Forecast
10.3.4 Southeast Asia Market Oncolytic Virus Manufacturing Services Forecast
10.3.5 India Market Oncolytic Virus Manufacturing Services Forecast
10.3.6 Australia Market Oncolytic Virus Manufacturing Services Forecast
10.4 Europe Oncolytic Virus Manufacturing Services Forecast by Country (2025-2030)
10.4.1 Germany Market Oncolytic Virus Manufacturing Services Forecast
10.4.2 France Market Oncolytic Virus Manufacturing Services Forecast
10.4.3 UK Market Oncolytic Virus Manufacturing Services Forecast
10.4.4 Italy Market Oncolytic Virus Manufacturing Services Forecast
10.4.5 Russia Market Oncolytic Virus Manufacturing Services Forecast
10.5 Middle East & Africa Oncolytic Virus Manufacturing Services Forecast by Region (2025-2030)
10.5.1 Egypt Market Oncolytic Virus Manufacturing Services Forecast
10.5.2 South Africa Market Oncolytic Virus Manufacturing Services Forecast
10.5.3 Israel Market Oncolytic Virus Manufacturing Services Forecast
10.5.4 Turkey Market Oncolytic Virus Manufacturing Services Forecast
10.6 Global Oncolytic Virus Manufacturing Services Forecast by Type (2025-2030)
10.7 Global Oncolytic Virus Manufacturing Services Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Oncolytic Virus Manufacturing Services Forecast
11 KEY PLAYERS ANALYSIS
11.1 Recipharm (Vibalogics)
11.1.1 Recipharm (Vibalogics) Company Information
11.1.2 Recipharm (Vibalogics) Oncolytic Virus Manufacturing Services Product Offered
11.1.3 Recipharm (Vibalogics) Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Recipharm (Vibalogics) Main Business Overview
11.1.5 Recipharm (Vibalogics) Latest Developments
11.2 IDT Biologika
11.2.1 IDT Biologika Company Information
11.2.2 IDT Biologika Oncolytic Virus Manufacturing Services Product Offered
11.2.3 IDT Biologika Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 IDT Biologika Main Business Overview
11.2.5 IDT Biologika Latest Developments
11.3 FUJIFILM Diosynth Biotechnologies
11.3.1 FUJIFILM Diosynth Biotechnologies Company Information
11.3.2 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing Services Product Offered
11.3.3 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.3.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.4 Exothera
11.4.1 Exothera Company Information
11.4.2 Exothera Oncolytic Virus Manufacturing Services Product Offered
11.4.3 Exothera Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Exothera Main Business Overview
11.4.5 Exothera Latest Developments
11.5 Lonza
11.5.1 Lonza Company Information
11.5.2 Lonza Oncolytic Virus Manufacturing Services Product Offered
11.5.3 Lonza Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Lonza Main Business Overview
11.5.5 Lonza Latest Developments
11.6 Creative Biolabs
11.6.1 Creative Biolabs Company Information
11.6.2 Creative Biolabs Oncolytic Virus Manufacturing Services Product Offered
11.6.3 Creative Biolabs Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Creative Biolabs Main Business Overview
11.6.5 Creative Biolabs Latest Developments
11.7 Takara Bio
11.7.1 Takara Bio Company Information
11.7.2 Takara Bio Oncolytic Virus Manufacturing Services Product Offered
11.7.3 Takara Bio Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Takara Bio Main Business Overview
11.7.5 Takara Bio Latest Developments
11.8 Libentech
11.8.1 Libentech Company Information
11.8.2 Libentech Oncolytic Virus Manufacturing Services Product Offered
11.8.3 Libentech Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Libentech Main Business Overview
11.8.5 Libentech Latest Developments
11.9 ABL
11.9.1 ABL Company Information
11.9.2 ABL Oncolytic Virus Manufacturing Services Product Offered
11.9.3 ABL Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 ABL Main Business Overview
11.9.5 ABL Latest Developments
11.10 Nabios
11.10.1 Nabios Company Information
11.10.2 Nabios Oncolytic Virus Manufacturing Services Product Offered
11.10.3 Nabios Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Nabios Main Business Overview
11.10.5 Nabios Latest Developments
11.11 Halix
11.11.1 Halix Company Information
11.11.2 Halix Oncolytic Virus Manufacturing Services Product Offered
11.11.3 Halix Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Halix Main Business Overview
11.11.5 Halix Latest Developments
11.12 Obio Technology
11.12.1 Obio Technology Company Information
11.12.2 Obio Technology Oncolytic Virus Manufacturing Services Product Offered
11.12.3 Obio Technology Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Obio Technology Main Business Overview
11.12.5 Obio Technology Latest Developments
11.13 Porton Advanced
11.13.1 Porton Advanced Company Information
11.13.2 Porton Advanced Oncolytic Virus Manufacturing Services Product Offered
11.13.3 Porton Advanced Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Porton Advanced Main Business Overview
11.13.5 Porton Advanced Latest Developments
11.14 WuXi ATU
11.14.1 WuXi ATU Company Information
11.14.2 WuXi ATU Oncolytic Virus Manufacturing Services Product Offered
11.14.3 WuXi ATU Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 WuXi ATU Main Business Overview
11.14.5 WuXi ATU Latest Developments
11.15 Genevoyager
11.15.1 Genevoyager Company Information
11.15.2 Genevoyager Oncolytic Virus Manufacturing Services Product Offered
11.15.3 Genevoyager Oncolytic Virus Manufacturing Services Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Genevoyager Main Business Overview
11.15.5 Genevoyager Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oncolytic Virus Manufacturing Services Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Oncolytic Virus Manufacturing Services Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Oncolytic Herpes Simplex Virus
Table 4. Major Players of Oncolytic Adenovirus
Table 5. Major Players of Oncolytic Vaccinia Virus
Table 6. Major Players of Others
Table 7. Oncolytic Virus Manufacturing Services Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 8. Global Oncolytic Virus Manufacturing Services Market Size by Type (2019-2024) & ($ millions)
Table 9. Global Oncolytic Virus Manufacturing Services Market Size Market Share by Type (2019-2024)
Table 10. Oncolytic Virus Manufacturing Services Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 11. Global Oncolytic Virus Manufacturing Services Market Size by Application (2019-2024) & ($ millions)
Table 12. Global Oncolytic Virus Manufacturing Services Market Size Market Share by Application (2019-2024)
Table 13. Global Oncolytic Virus Manufacturing Services Revenue by Player (2019-2024) & ($ millions)
Table 14. Global Oncolytic Virus Manufacturing Services Revenue Market Share by Player (2019-2024)
Table 15. Oncolytic Virus Manufacturing Services Key Players Head office and Products Offered
Table 16. Oncolytic Virus Manufacturing Services Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Oncolytic Virus Manufacturing Services Market Size by Region (2019-2024) & ($ millions)
Table 20. Global Oncolytic Virus Manufacturing Services Market Size Market Share by Region (2019-2024)
Table 21. Global Oncolytic Virus Manufacturing Services Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Oncolytic Virus Manufacturing Services Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Oncolytic Virus Manufacturing Services Market Size by Country (2019-2024) & ($ millions)
Table 24. Americas Oncolytic Virus Manufacturing Services Market Size Market Share by Country (2019-2024)
Table 25. Americas Oncolytic Virus Manufacturing Services Market Size by Type (2019-2024) & ($ millions)
Table 26. Americas Oncolytic Virus Manufacturing Services Market Size Market Share by Type (2019-2024)
Table 27. Americas Oncolytic Virus Manufacturing Services Market Size by Application (2019-2024) & ($ millions)
Table 28. Americas Oncolytic Virus Manufacturing Services Market Size Market Share by Application (2019-2024)
Table 29. APAC Oncolytic Virus Manufacturing Services Market Size by Region (2019-2024) & ($ millions)
Table 30. APAC Oncolytic Virus Manufacturing Services Market Size Market Share by Region (2019-2024)
Table 31. APAC Oncolytic Virus Manufacturing Services Market Size by Type (2019-2024) & ($ millions)
Table 32. APAC Oncolytic Virus Manufacturing Services Market Size by Application (2019-2024) & ($ millions)
Table 33. Europe Oncolytic Virus Manufacturing Services Market Size by Country (2019-2024) & ($ millions)
Table 34. Europe Oncolytic Virus Manufacturing Services Market Size Market Share by Country (2019-2024)
Table 35. Europe Oncolytic Virus Manufacturing Services Market Size by Type (2019-2024) & ($ millions)
Table 36. Europe Oncolytic Virus Manufacturing Services Market Size by Application (2019-2024) & ($ millions)
Table 37. Middle East & Africa Oncolytic Virus Manufacturing Services Market Size by Region (2019-2024) & ($ millions)
Table 38. Middle East & Africa Oncolytic Virus Manufacturing Services Market Size by Type (2019-2024) & ($ millions)
Table 39. Middle East & Africa Oncolytic Virus Manufacturing Services Market Size by Application (2019-2024) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Oncolytic Virus Manufacturing Services
Table 41. Key Market Challenges & Risks of Oncolytic Virus Manufacturing Services
Table 42. Key Industry Trends of Oncolytic Virus Manufacturing Services
Table 43. Global Oncolytic Virus Manufacturing Services Market Size Forecast by Region (2025-2030) & ($ millions)
Table 44. Global Oncolytic Virus Manufacturing Services Market Size Market Share Forecast by Region (2025-2030)
Table 45. Global Oncolytic Virus Manufacturing Services Market Size Forecast by Type (2025-2030) & ($ millions)
Table 46. Global Oncolytic Virus Manufacturing Services Market Size Forecast by Application (2025-2030) & ($ millions)
Table 47. Recipharm (Vibalogics) Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 48. Recipharm (Vibalogics) Oncolytic Virus Manufacturing Services Product Offered
Table 49. Recipharm (Vibalogics) Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 50. Recipharm (Vibalogics) Main Business
Table 51. Recipharm (Vibalogics) Latest Developments
Table 52. IDT Biologika Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 53. IDT Biologika Oncolytic Virus Manufacturing Services Product Offered
Table 54. IDT Biologika Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. IDT Biologika Main Business
Table 56. IDT Biologika Latest Developments
Table 57. FUJIFILM Diosynth Biotechnologies Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 58. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing Services Product Offered
Table 59. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. FUJIFILM Diosynth Biotechnologies Main Business
Table 61. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 62. Exothera Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 63. Exothera Oncolytic Virus Manufacturing Services Product Offered
Table 64. Exothera Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Exothera Main Business
Table 66. Exothera Latest Developments
Table 67. Lonza Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 68. Lonza Oncolytic Virus Manufacturing Services Product Offered
Table 69. Lonza Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Lonza Main Business
Table 71. Lonza Latest Developments
Table 72. Creative Biolabs Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 73. Creative Biolabs Oncolytic Virus Manufacturing Services Product Offered
Table 74. Creative Biolabs Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Creative Biolabs Main Business
Table 76. Creative Biolabs Latest Developments
Table 77. Takara Bio Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 78. Takara Bio Oncolytic Virus Manufacturing Services Product Offered
Table 79. Takara Bio Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Takara Bio Main Business
Table 81. Takara Bio Latest Developments
Table 82. Libentech Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 83. Libentech Oncolytic Virus Manufacturing Services Product Offered
Table 84. Libentech Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Libentech Main Business
Table 86. Libentech Latest Developments
Table 87. ABL Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 88. ABL Oncolytic Virus Manufacturing Services Product Offered
Table 89. ABL Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. ABL Main Business
Table 91. ABL Latest Developments
Table 92. Nabios Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 93. Nabios Oncolytic Virus Manufacturing Services Product Offered
Table 94. Nabios Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Nabios Main Business
Table 96. Nabios Latest Developments
Table 97. Halix Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 98. Halix Oncolytic Virus Manufacturing Services Product Offered
Table 99. Halix Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Halix Main Business
Table 101. Halix Latest Developments
Table 102. Obio Technology Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 103. Obio Technology Oncolytic Virus Manufacturing Services Product Offered
Table 104. Obio Technology Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Obio Technology Main Business
Table 106. Obio Technology Latest Developments
Table 107. Porton Advanced Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 108. Porton Advanced Oncolytic Virus Manufacturing Services Product Offered
Table 109. Porton Advanced Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Porton Advanced Main Business
Table 111. Porton Advanced Latest Developments
Table 112. WuXi ATU Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 113. WuXi ATU Oncolytic Virus Manufacturing Services Product Offered
Table 114. WuXi ATU Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. WuXi ATU Main Business
Table 116. WuXi ATU Latest Developments
Table 117. Genevoyager Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 118. Genevoyager Oncolytic Virus Manufacturing Services Product Offered
Table 119. Genevoyager Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Genevoyager Main Business
Table 121. Genevoyager Latest Developments
Table 1. Oncolytic Virus Manufacturing Services Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Oncolytic Virus Manufacturing Services Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Oncolytic Herpes Simplex Virus
Table 4. Major Players of Oncolytic Adenovirus
Table 5. Major Players of Oncolytic Vaccinia Virus
Table 6. Major Players of Others
Table 7. Oncolytic Virus Manufacturing Services Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 8. Global Oncolytic Virus Manufacturing Services Market Size by Type (2019-2024) & ($ millions)
Table 9. Global Oncolytic Virus Manufacturing Services Market Size Market Share by Type (2019-2024)
Table 10. Oncolytic Virus Manufacturing Services Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 11. Global Oncolytic Virus Manufacturing Services Market Size by Application (2019-2024) & ($ millions)
Table 12. Global Oncolytic Virus Manufacturing Services Market Size Market Share by Application (2019-2024)
Table 13. Global Oncolytic Virus Manufacturing Services Revenue by Player (2019-2024) & ($ millions)
Table 14. Global Oncolytic Virus Manufacturing Services Revenue Market Share by Player (2019-2024)
Table 15. Oncolytic Virus Manufacturing Services Key Players Head office and Products Offered
Table 16. Oncolytic Virus Manufacturing Services Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Oncolytic Virus Manufacturing Services Market Size by Region (2019-2024) & ($ millions)
Table 20. Global Oncolytic Virus Manufacturing Services Market Size Market Share by Region (2019-2024)
Table 21. Global Oncolytic Virus Manufacturing Services Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Oncolytic Virus Manufacturing Services Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Oncolytic Virus Manufacturing Services Market Size by Country (2019-2024) & ($ millions)
Table 24. Americas Oncolytic Virus Manufacturing Services Market Size Market Share by Country (2019-2024)
Table 25. Americas Oncolytic Virus Manufacturing Services Market Size by Type (2019-2024) & ($ millions)
Table 26. Americas Oncolytic Virus Manufacturing Services Market Size Market Share by Type (2019-2024)
Table 27. Americas Oncolytic Virus Manufacturing Services Market Size by Application (2019-2024) & ($ millions)
Table 28. Americas Oncolytic Virus Manufacturing Services Market Size Market Share by Application (2019-2024)
Table 29. APAC Oncolytic Virus Manufacturing Services Market Size by Region (2019-2024) & ($ millions)
Table 30. APAC Oncolytic Virus Manufacturing Services Market Size Market Share by Region (2019-2024)
Table 31. APAC Oncolytic Virus Manufacturing Services Market Size by Type (2019-2024) & ($ millions)
Table 32. APAC Oncolytic Virus Manufacturing Services Market Size by Application (2019-2024) & ($ millions)
Table 33. Europe Oncolytic Virus Manufacturing Services Market Size by Country (2019-2024) & ($ millions)
Table 34. Europe Oncolytic Virus Manufacturing Services Market Size Market Share by Country (2019-2024)
Table 35. Europe Oncolytic Virus Manufacturing Services Market Size by Type (2019-2024) & ($ millions)
Table 36. Europe Oncolytic Virus Manufacturing Services Market Size by Application (2019-2024) & ($ millions)
Table 37. Middle East & Africa Oncolytic Virus Manufacturing Services Market Size by Region (2019-2024) & ($ millions)
Table 38. Middle East & Africa Oncolytic Virus Manufacturing Services Market Size by Type (2019-2024) & ($ millions)
Table 39. Middle East & Africa Oncolytic Virus Manufacturing Services Market Size by Application (2019-2024) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Oncolytic Virus Manufacturing Services
Table 41. Key Market Challenges & Risks of Oncolytic Virus Manufacturing Services
Table 42. Key Industry Trends of Oncolytic Virus Manufacturing Services
Table 43. Global Oncolytic Virus Manufacturing Services Market Size Forecast by Region (2025-2030) & ($ millions)
Table 44. Global Oncolytic Virus Manufacturing Services Market Size Market Share Forecast by Region (2025-2030)
Table 45. Global Oncolytic Virus Manufacturing Services Market Size Forecast by Type (2025-2030) & ($ millions)
Table 46. Global Oncolytic Virus Manufacturing Services Market Size Forecast by Application (2025-2030) & ($ millions)
Table 47. Recipharm (Vibalogics) Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 48. Recipharm (Vibalogics) Oncolytic Virus Manufacturing Services Product Offered
Table 49. Recipharm (Vibalogics) Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 50. Recipharm (Vibalogics) Main Business
Table 51. Recipharm (Vibalogics) Latest Developments
Table 52. IDT Biologika Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 53. IDT Biologika Oncolytic Virus Manufacturing Services Product Offered
Table 54. IDT Biologika Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. IDT Biologika Main Business
Table 56. IDT Biologika Latest Developments
Table 57. FUJIFILM Diosynth Biotechnologies Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 58. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing Services Product Offered
Table 59. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. FUJIFILM Diosynth Biotechnologies Main Business
Table 61. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 62. Exothera Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 63. Exothera Oncolytic Virus Manufacturing Services Product Offered
Table 64. Exothera Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Exothera Main Business
Table 66. Exothera Latest Developments
Table 67. Lonza Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 68. Lonza Oncolytic Virus Manufacturing Services Product Offered
Table 69. Lonza Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Lonza Main Business
Table 71. Lonza Latest Developments
Table 72. Creative Biolabs Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 73. Creative Biolabs Oncolytic Virus Manufacturing Services Product Offered
Table 74. Creative Biolabs Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Creative Biolabs Main Business
Table 76. Creative Biolabs Latest Developments
Table 77. Takara Bio Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 78. Takara Bio Oncolytic Virus Manufacturing Services Product Offered
Table 79. Takara Bio Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Takara Bio Main Business
Table 81. Takara Bio Latest Developments
Table 82. Libentech Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 83. Libentech Oncolytic Virus Manufacturing Services Product Offered
Table 84. Libentech Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Libentech Main Business
Table 86. Libentech Latest Developments
Table 87. ABL Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 88. ABL Oncolytic Virus Manufacturing Services Product Offered
Table 89. ABL Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. ABL Main Business
Table 91. ABL Latest Developments
Table 92. Nabios Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 93. Nabios Oncolytic Virus Manufacturing Services Product Offered
Table 94. Nabios Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Nabios Main Business
Table 96. Nabios Latest Developments
Table 97. Halix Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 98. Halix Oncolytic Virus Manufacturing Services Product Offered
Table 99. Halix Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Halix Main Business
Table 101. Halix Latest Developments
Table 102. Obio Technology Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 103. Obio Technology Oncolytic Virus Manufacturing Services Product Offered
Table 104. Obio Technology Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Obio Technology Main Business
Table 106. Obio Technology Latest Developments
Table 107. Porton Advanced Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 108. Porton Advanced Oncolytic Virus Manufacturing Services Product Offered
Table 109. Porton Advanced Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Porton Advanced Main Business
Table 111. Porton Advanced Latest Developments
Table 112. WuXi ATU Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 113. WuXi ATU Oncolytic Virus Manufacturing Services Product Offered
Table 114. WuXi ATU Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. WuXi ATU Main Business
Table 116. WuXi ATU Latest Developments
Table 117. Genevoyager Details, Company Type, Oncolytic Virus Manufacturing Services Area Served and Its Competitors
Table 118. Genevoyager Oncolytic Virus Manufacturing Services Product Offered
Table 119. Genevoyager Oncolytic Virus Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Genevoyager Main Business
Table 121. Genevoyager Latest Developments
LIST OF FIGURES
Figure 1. Oncolytic Virus Manufacturing Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncolytic Virus Manufacturing Services Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Oncolytic Virus Manufacturing Services Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Oncolytic Virus Manufacturing Services Sales Market Share by Country/Region (2023)
Figure 8. Oncolytic Virus Manufacturing Services Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Oncolytic Virus Manufacturing Services Market Size Market Share by Type in 2023
Figure 10. Oncolytic Virus Manufacturing Services in R&D
Figure 11. Global Oncolytic Virus Manufacturing Services Market: R&D (2019-2024) & ($ millions)
Figure 12. Oncolytic Virus Manufacturing Services in Biopharmaceutical Manufacturers
Figure 13. Global Oncolytic Virus Manufacturing Services Market: Biopharmaceutical Manufacturers (2019-2024) & ($ millions)
Figure 14. Oncolytic Virus Manufacturing Services in Others
Figure 15. Global Oncolytic Virus Manufacturing Services Market: Others (2019-2024) & ($ millions)
Figure 16. Global Oncolytic Virus Manufacturing Services Market Size Market Share by Application in 2023
Figure 17. Global Oncolytic Virus Manufacturing Services Revenue Market Share by Player in 2023
Figure 18. Global Oncolytic Virus Manufacturing Services Market Size Market Share by Region (2019-2024)
Figure 19. Americas Oncolytic Virus Manufacturing Services Market Size 2019-2024 ($ millions)
Figure 20. APAC Oncolytic Virus Manufacturing Services Market Size 2019-2024 ($ millions)
Figure 21. Europe Oncolytic Virus Manufacturing Services Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Oncolytic Virus Manufacturing Services Market Size 2019-2024 ($ millions)
Figure 23. Americas Oncolytic Virus Manufacturing Services Value Market Share by Country in 2023
Figure 24. United States Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Oncolytic Virus Manufacturing Services Market Size Market Share by Region in 2023
Figure 29. APAC Oncolytic Virus Manufacturing Services Market Size Market Share by Type (2019-2024)
Figure 30. APAC Oncolytic Virus Manufacturing Services Market Size Market Share by Application (2019-2024)
Figure 31. China Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 35. India Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Oncolytic Virus Manufacturing Services Market Size Market Share by Country in 2023
Figure 38. Europe Oncolytic Virus Manufacturing Services Market Size Market Share by Type (2019-2024)
Figure 39. Europe Oncolytic Virus Manufacturing Services Market Size Market Share by Application (2019-2024)
Figure 40. Germany Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 41. France Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Oncolytic Virus Manufacturing Services Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Oncolytic Virus Manufacturing Services Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Oncolytic Virus Manufacturing Services Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 54. APAC Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 55. Europe Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 57. United States Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 58. Canada Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 59. Mexico Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 60. Brazil Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 61. China Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 62. Japan Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 63. Korea Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 65. India Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 66. Australia Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 67. Germany Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 68. France Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 69. UK Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 70. Italy Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 71. Russia Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 72. Egypt Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 73. South Africa Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 74. Israel Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 75. Turkey Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 77. Global Oncolytic Virus Manufacturing Services Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Oncolytic Virus Manufacturing Services Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Oncolytic Virus Manufacturing Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncolytic Virus Manufacturing Services Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Oncolytic Virus Manufacturing Services Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Oncolytic Virus Manufacturing Services Sales Market Share by Country/Region (2023)
Figure 8. Oncolytic Virus Manufacturing Services Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Oncolytic Virus Manufacturing Services Market Size Market Share by Type in 2023
Figure 10. Oncolytic Virus Manufacturing Services in R&D
Figure 11. Global Oncolytic Virus Manufacturing Services Market: R&D (2019-2024) & ($ millions)
Figure 12. Oncolytic Virus Manufacturing Services in Biopharmaceutical Manufacturers
Figure 13. Global Oncolytic Virus Manufacturing Services Market: Biopharmaceutical Manufacturers (2019-2024) & ($ millions)
Figure 14. Oncolytic Virus Manufacturing Services in Others
Figure 15. Global Oncolytic Virus Manufacturing Services Market: Others (2019-2024) & ($ millions)
Figure 16. Global Oncolytic Virus Manufacturing Services Market Size Market Share by Application in 2023
Figure 17. Global Oncolytic Virus Manufacturing Services Revenue Market Share by Player in 2023
Figure 18. Global Oncolytic Virus Manufacturing Services Market Size Market Share by Region (2019-2024)
Figure 19. Americas Oncolytic Virus Manufacturing Services Market Size 2019-2024 ($ millions)
Figure 20. APAC Oncolytic Virus Manufacturing Services Market Size 2019-2024 ($ millions)
Figure 21. Europe Oncolytic Virus Manufacturing Services Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Oncolytic Virus Manufacturing Services Market Size 2019-2024 ($ millions)
Figure 23. Americas Oncolytic Virus Manufacturing Services Value Market Share by Country in 2023
Figure 24. United States Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Oncolytic Virus Manufacturing Services Market Size Market Share by Region in 2023
Figure 29. APAC Oncolytic Virus Manufacturing Services Market Size Market Share by Type (2019-2024)
Figure 30. APAC Oncolytic Virus Manufacturing Services Market Size Market Share by Application (2019-2024)
Figure 31. China Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 35. India Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Oncolytic Virus Manufacturing Services Market Size Market Share by Country in 2023
Figure 38. Europe Oncolytic Virus Manufacturing Services Market Size Market Share by Type (2019-2024)
Figure 39. Europe Oncolytic Virus Manufacturing Services Market Size Market Share by Application (2019-2024)
Figure 40. Germany Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 41. France Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Oncolytic Virus Manufacturing Services Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Oncolytic Virus Manufacturing Services Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Oncolytic Virus Manufacturing Services Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Oncolytic Virus Manufacturing Services Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 54. APAC Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 55. Europe Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 57. United States Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 58. Canada Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 59. Mexico Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 60. Brazil Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 61. China Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 62. Japan Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 63. Korea Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 65. India Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 66. Australia Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 67. Germany Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 68. France Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 69. UK Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 70. Italy Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 71. Russia Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 72. Egypt Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 73. South Africa Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 74. Israel Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 75. Turkey Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Oncolytic Virus Manufacturing Services Market Size 2025-2030 ($ millions)
Figure 77. Global Oncolytic Virus Manufacturing Services Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Oncolytic Virus Manufacturing Services Market Size Market Share Forecast by Application (2025-2030)
